Clicky

Abbott Laboratories(ABL)

Description: Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.


Keywords: Medicine Life Sciences Pain Diabetes Medical Device Inflammation Hypertension Influenza Cardiovascular Disease Automation Solutions Health Care Products HIV Medical Test Molecular Diagnostics Heart Failure Chronic Pain Migraine Fever Irritable Bowel Syndrome Point Of Care Testing Generic Pharmaceuticals Movement Disorders Dyslipidemia Hypothyroidism Clarithromycin Hormone Replacement Therapy Infectious Agents Lake Bluff Intrahepatic Cholestasis Treatment Of Cardiovascular Diseases Alere Biliary Spasm Care Systems Laboratory Systems Ménière's Disease Pediatric And Adult Nutritional Products Structural Heart Devices

Home Page: www.abbott.com

100 Abbott Park Road
North Chicago, IL 60064-6400
United States
Phone: 224 667 6100


Officers

Name Title
Mr. Robert B. Ford Chairman, Pres & CEO
Mr. Robert E. Funck Jr. Exec. VP of Fin. & CFO
Mr. Hubert L. Allen Exec. VP, Gen. Counsel & Sec.
Mr. Daniel Gesua Sive Salvadori Exec. VP and Group Pres of Established Pharmaceuticals & Nutritional Products
Ms. Andrea F. Wainer Exec. VP of Rapid & Molecular Diagnostics
Mr. Scott Michael Leinenweber VP of Investor Relations, Licensing & Acquisitions
James E. Young VP and Chief Ethics & Compliance Officer
Ms. Melissa Brotz VP of Public Affairs & Corp. Marketing
Ms. Elaine R. Leavenworth Sr. VP and Chief Marketing & External Affairs Officer
Ms. Mary K. Moreland Exec. VP of HR

Exchange: XETRA

Country: DE

Currency: Euro (€)

Forward PE: 24.4499
Trailing PE: 25.0144
Price-to-Book MRQ: 5.2845
Price-to-Sales TTM: 4.0941
IPO Date:
Fiscal Year End: December
Full Time Employees: 113000
Back to stocks